[1]
“EFFECT OF ZANJABĪL (ZINGIBER OFFICINALE) IN NON-ALCOHOLIC FATTY LIVER DISEASE- A RANDOMIZED CONTROLLED TRIAL”, Int J Ayu Pharm Res, vol. 8, no. Supply2, pp. 43–53, Nov. 2020, doi: 10.47070/ijapr.v8iSupply2.1694.